- Did you mean
- aggregated
Search results - 2 results
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
and EIA were in high agreement (Cohen’s kappa = 0.969) for the detection of 14 hrHPVs in aggregate, and no significant difference was observed (McNemar’s P = 0.629). The LMNX internal control detected ...